• Exchange: LSE EuropeQS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

UCB:LI

57.880 EUR 0.210 0.36%

As of 11:23:29 ET on 04/17/2014.

Snapshot for UCB SA (UCB)

Open: 57.935 Day's Range: 57.530 - 58.190 Volume: 11,045
Previous Close: 57.670 52wk Range: 38.040 - 59.605 1-Yr Rtn: +26.80%

Stock Chart for UCB

No chart data available.
  • UCB:LI 57.875
  • 1D
  • 1M
  • 1Y
57.670
Interactive UCB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UCB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 28.6251
Relative P/E vs. UKX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.0220
Est. PEG Ratio 2.0053
Market Cap (M EUR) 11,257.99
Shares Outstanding (M) 194.51
30 Day Average Volume 7,717
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.80%
Cash Dividend (EUR) 0.7800
Dividend Ex-Date 04/29/2014
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UCB

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for UCB

UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders, inflammatory diseases, and oncology. UCB operates worldwide.

Roch F DoliveuxChief Executive OfficerJean-Christophe TellierExec VP:Biopharma/CEO-Elect
Detlef ThielgenExec VP/CFOIsmail KolaExec VP/Pres:Newmedicines
More Company Profile & Key Executives for UCB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil